COMMUNIQUÉS West-GlobeNewswire

Galectin Therapeutics CEO Peter G. Traber, M.D. Named Chair of the Anti-Fibrotic Drug Development Summit 2017

13/11/2017 - 15:00

NORCROSS, Ga., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT ), the leading developer of therapeutics that target galectin proteins, announced that Peter G. Traber, M.D., the Company's chief [...]

CEO Kym Anthony Discusses 2017 Miles Stones and Product Developments

13/11/2017 - 15:00

Ottawa, ONT , Nov. 13, 2017 (GLOBE NEWSWIRE) -- Kym Anthony CEO of Avivagen, Inc. (“Company”) (TSX-V: VIV ), (OTCPink: CHEXF ) interviews with host Everett Jolly on the Uptick Network Stock Day Podcast. In the first [...]

Cytori Announces New U.S. Investigator Trial for Hip Osteonecrosis

13/11/2017 - 15:00

SAN DIEGO, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (Nasdaq: CYTX ) (“Cytori” or “the Company”) today announced a new investigator initiated U.S. clinical trial for hip osteonecrosis. Details of the [...]

Akers Biosciences Announces Conference Call to Discuss Q3 2017 Earnings

13/11/2017 - 15:00

THOROFARE, N.J., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, will hold a conference call [...]

Repros Therapeutics Inc.® Reports Third Quarter 2017 Financial Results

13/11/2017 - 14:45

THE WOODLANDS, Texas, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.® (Nasdaq: RPRX ) today announced financial results for the third quarter ended September 30, 2017. Financial Results Net loss for the [...]

Abeona Management to Present at Multiple Conferences in November

13/11/2017 - 14:45

NEW YORK and CLEVELAND, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ: ABEO ), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life- [...]

ProPhase Labs Reports Financial Results for the Three Months and Nine Months Ended September 30, 2017

13/11/2017 - 14:30

DOYLESTOWN, Pennsylvania, Nov. 13, 2017 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH ) ( www.ProPhaseLabs.com ) today reported its financial results for the three months and nine months ended September 30, 2017 [...]

EHNAC Congratulates PokitDok on Achieving HITRUST CSF™ Certification

13/11/2017 - 14:30

FARMINGTON, Conn., Nov. 13, 2017 (GLOBE NEWSWIRE) -- The Electronic Healthcare Network Accreditation Commission (EHNAC), a non-profit standards development organization and accrediting body for organizations that [...]

Assure Holdings Performs First Neuromonitoring Case in Texas

13/11/2017 - 14:30

PARKER, Colo., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSX-V: IOM ) (OTCQB:ARHH), a provider of intraoperative neuromonitoring services, has performed its first [...]

International Stem Cell Corporation Announces Positive Interim Clinical Results for Parkinson's Disease Clinical Trial

13/11/2017 - 14:30

CARLSBAD, Calif., Nov. 13, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products [...]

Cidara Therapeutics Named a San Diego Metro Area 2017 Top Workplace

13/11/2017 - 14:30

SAN DIEGO, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX ), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that it has been named a 2017 [...]

Combination Immunotherapy of Pembrolizumab with the Galectin-3 Inhibitor GR-MD-02 Shows Promising Early Results in Treatment of Advanced Melanoma from a Phase 1b Clinical Trial

13/11/2017 - 14:30

NORCROSS, Ga., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT ), the leading developer of therapeutics that target galectin proteins, and Providence Cancer Institute today announced the [...]

BriaCell Announces Advancement of its Small Molecule Program and Patent Allowance

13/11/2017 - 14:30

BERKELEY, Calif. and VANCOUVER, British Columbia, Nov. 13, 2017 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V: BCT ) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company [...]

SteadyMed Reports Third Quarter 2017 Financial Results and Provides Corporate Update

13/11/2017 - 14:30

SAN RAMON, Calif., Nov. 13, 2017 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq: STDY ), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and high-value diseases with [...]

80% of Prostate Cancer Patients in OncBioMune Phase 1 Clinical Trial of ProscaVax Show No Disease Progression at the First Post-Therapy Follow-up

13/11/2017 - 14:25

BATON ROUGE, La., Nov. 13, 2017 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged in the development of a proprietary [...]

Peregrine Announces Date of 2017 Annual Meeting of Stockholders

13/11/2017 - 14:05

TUSTIN, Calif., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM ) (NASDAQ: PPHMP ) today announced that its 2017 Annual Meeting of Stockholders will be held on January 18, 2018, at 14191 [...]

Nexstim gains FDA clearance to commercialise its NBT® system in the US for the treatment of depression

13/11/2017 - 14:02

C ompany announcement, Helsinki, 13 November 2017 at 3 pm Nexstim Plc (NXTMH:HEX, NXTMS:STO) (" Nexstim " or " Company "), a medical technology company developing and marketing pioneering navigated non-invasive brain [...]

Medtronic to Present New Clinical Data on Vascular Interventions and Key Symposia at VEITHsymposium 2017

13/11/2017 - 14:01

DUBLIN - November 13, 2017 - Medtronic plc (NYSE: MDT) today announced several noteworthy presentations of clinical studies and symposia on aortic, peripheral, endoVenous, and vascular embolization therapies at the 44 [...]

Fibrocell Reports Third Quarter 2017 Financial Results and Recent Highlights

13/11/2017 - 14:00

EXTON, Pa., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ: FCSC ), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today [...]